Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study
- PMID: 29895655
- PMCID: PMC6009554
- DOI: 10.1136/bmjopen-2017-021367
Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study
Abstract
Objective: For many individuals with Lyme disease, prompt treatment leads to rapid resolution of infection. However, severe complications can occur if treatment is delayed. Our objective was to identify themes around belated diagnosis or treatment of Lyme disease using the General Model of Total Patient Delay (GMTPD).
Design: We conducted a qualitative interview study using indepth telephone interviews.
Setting: Participants were patients from a large, integrated health system in the state of Pennsylvania, USA.
Participants: There were 26 participants. Participants had to have a diagnosis of Lyme disease between 2014 and 2017 and a positive IgG western blot. We used a stratified purposeful sampling design to identify patients with and without late Lyme disease manifestations. To ensure variation in care experiences, we oversampled patients diagnosed outside of primary care.
Outcome measures: We asked participants about their experience from first Lyme disease symptoms to treatment. We applied an iterative coding process to identify key themes and then synthesised codes into higher order codes representing the GMTPD stages: appraisal delay (symptom to recognition of illness); illness delay (inferring illness to deciding to seek help); behavioural delay (deciding to seek help to the act of seeking help); scheduling delay (seeking help to attending an appointment); and treatment delay (attending appointment to treatment).
Results: Appraisal delay themes included symptom misattribution, intermittent symptoms and misperceptions about the necessity of a bull's-eye rash. Health insurance status was a driver of illness and behavioural delays. Scheduling delay was not noted by participants, in part, because 10 of the 26 patients went to urgent care or emergency department settings. Misdiagnoses were more common in these settings, contributing to treatment delay.
Conclusion: Our study identified potentially modifiable risk factors for belated treatment. Targeting these risk factors may minimise time to treatment and reduce the occurrence of preventable complications.
Keywords: lyme disease; patient delay; qualitative research; social medicine.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study.BMJ Open. 2017 Sep 3;7(9):e015682. doi: 10.1136/bmjopen-2016-015682. BMJ Open. 2017. PMID: 28871013 Free PMC article.
-
A qualitative approach to understanding patients' diagnosis of Lyme disease.Public Health Nurs. 2006 Jan-Feb;23(1):20-6. doi: 10.1111/j.0737-1209.2006.230104.x. Public Health Nurs. 2006. PMID: 16460417
-
Patients' Experiences of Cancer Diagnosis as a Result of an Emergency Presentation: A Qualitative Study.PLoS One. 2015 Aug 7;10(8):e0135027. doi: 10.1371/journal.pone.0135027. eCollection 2015. PLoS One. 2015. PMID: 26252203 Free PMC article.
-
Emergency department presentations of Lyme disease in children.Pediatr Emerg Care. 1998 Oct;14(5):356-61. Pediatr Emerg Care. 1998. PMID: 9814407 Review.
-
The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement.Arch Intern Med. 1996 Jul 22;156(14):1493-500. doi: 10.1001/archinte.156.14.1493. Arch Intern Med. 1996. PMID: 8687256 Review.
Cited by
-
By-degree Health and Economic Impacts of Lyme Disease, Eastern and Midwestern United States.Ecohealth. 2024 Mar;21(1):56-70. doi: 10.1007/s10393-024-01676-9. Epub 2024 Mar 13. Ecohealth. 2024. PMID: 38478199 Free PMC article.
-
What a Tick Can Tell a Doctor: Using the Human-Biting Tick in the Clinical Management of Tick-Borne Disease.J Clin Med. 2023 Oct 14;12(20):6522. doi: 10.3390/jcm12206522. J Clin Med. 2023. PMID: 37892661 Free PMC article.
-
Experience and knowledge of Lyme disease: A scoping review of patient-provider communication.Ticks Tick Borne Dis. 2021 Jul;12(4):101714. doi: 10.1016/j.ttbdis.2021.101714. Epub 2021 Mar 23. Ticks Tick Borne Dis. 2021. PMID: 33780825 Free PMC article.
-
Recent Progress in Lyme Disease and Remaining Challenges.Front Med (Lausanne). 2021 Aug 18;8:666554. doi: 10.3389/fmed.2021.666554. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34485323 Free PMC article. Review.
-
Development, Optimization, and Validation of a Quantitative PCR Assay for Borrelia burgdorferi Detection in Tick, Wildlife, and Human Samples.Pathogens. 2024 Nov 23;13(12):1034. doi: 10.3390/pathogens13121034. Pathogens. 2024. PMID: 39770294 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Lyme Disease: Data and statistics. 2016. https://www.cdc.gov/lyme/stats/index.html (accessed Oct 2017).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical